Status:
ACTIVE_NOT_RECRUITING
From PSA to Stockholm3: Study Part 1
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
This part of the project aims to analyze the effectiveness of the Stockholm3 test in regular clinical practice, both in general practice and in the specialist health care, as a tool for detecting pati...
Detailed Description
Background: Prostate cancer constitutes about 15 % of new cases of cancer among men globally, but about 27 % of all new cases of cancer in men in Norway. It is also the leading cause of cancer death ...
Eligibility Criteria
Inclusion
- All men where a physicians in regular clinical work finds that there is an indication to take the test
Exclusion
- known prostate cancer
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2030
Estimated Enrollment :
13431 Patients enrolled
Trial Details
Trial ID
NCT03381105
Start Date
September 1 2017
End Date
December 31 2030
Last Update
April 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stavanger University Hospital
Stavanger, Norway